Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer

Por Tagawa, Scott T, Beltran, Himisha
Publicado em 2011

Primary Squamous Cell Carcinoma of the Urinary Bladder Presenting as Peritoneal Carcinomatosis

Por Beltran, Himisha, Robinson, Brian D., Tagawa, Scott T.
Publicado em 2010

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer

Por Smith, Michael J., Akhtar, Naveed H., Tagawa, Scott T.
Publicado em 2012

Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib

Por Beltran, Himisha, Kaur, Gurveen, de España, Carmen Garcías, Tagawa, Scott T
Publicado em 2014

Novel molecular targets for urothelial carcinoma

Por Faltas, Bishoy M., Karir, Beerinder S., Tagawa, Scott T., Rosenberg, Jonathan E.
Publicado no Expert Opin Ther Targets (2015)

Prostate-Specific Membrane Antigen-Based Therapeutics

Por Akhtar, Naveed H., Pail, Orrin, Saran, Ankeeta, Tyrell, Lauren, Tagawa, Scott T.
Publicado em 2012

Immunologics and Chemotherapeutics for Renal Cell Carcinoma

Por Diamond, Elan, Riches, Jamie, Faltas, Bishoy, Tagawa, Scott T., Nanus, David M.
Publicado em 2014

Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radio...

Por Kosuri, Satyajit, Akhtar, Naveed H., Smith, Michael, Osborne, Joseph R., Tagawa, Scott T.
Publicado em 2012

PET/CT imaging and radioimmunotherapy of prostate cancer

Por Bouchelouche, Kirsten, Tagawa, Scott T., Goldsmith, Stanley J., Turkbey, Baris, Capala, Jacek, Choyke, Peter
Publicado em 2011

PROSTATE SPECIFIC MEMBRANE ANTIGEN-BASED IMAGING

Por Osborne, Joseph R., Akhtar, Naveed H., Vallabhajosula, Shankar, Anand, Alok, Deh, Kofi, Tagawa, Scott T.
Publicado em 2012

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

Por Galletti, Giuseppe, Portella, Luigi, Tagawa, Scott T., Kirby, Brian J., Giannakakou, Paraskevi, Nanus, David M.
Publicado em 2014

Microtubule inhibitor-based antibody–drug conjugates for cancer therapy

Por Klute, Kelsey, Nackos, Eleni, Tasaki, Shinsuke, Nguyen, Daniel P, Bander, Neil H, Tagawa, Scott T
Publicado no Onco Targets Ther (2014)

Isolation and characterization of circulating tumor cells in prostate cancer

Por Diamond, Elan, Lee, Guang Yu, Akhtar, Naveed H., Kirby, Brian J., Giannakakou, Paraskevi, Tagawa, Scott T., Nanus, David M.
Publicado em 2012

Anti-Prostate Specific Membrane Antigen-based Radioimmunotherapy for Prostate Cancer

Por Tagawa, Scott T., Beltran, Himisha, Vallabhajosula, Shankar, Goldsmith, Stanley J., Osborne, Joseph, Matulich, Dan, Petrillo, Kristen, Parmar, Sarojben, Nanus, David M., Bander, Neil H.
Publicado em 2010

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically-enhanced differential immunocapture (GEDI) and a prostate specific antibody

Por Gleghorn, Jason P., Pratt, Erica D., Denning, Denise, Liu, He, Bander, Neil H., Tagawa, Scott T., Nanus, David M., Giannakakou, Paraskevi A., Kirby, Brian J.
Publicado em 2009

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant...

Por Tagawa, Scott T., Akhtar, Naveed H., Nikolopoulou, Anastasia, Kaur, Gurveen, Robinson, Brian, Kahn, Renee, Vallabhajosula, Shankar, Goldsmith, Stanley J., Nanus, David M., Bander, Neil H.
Publicado em 2013

Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer

Por Darshan, Medha S., Loftus, Matthew S., Thadani-Mulero, Maria, Levy, Ben P., Escuin, Daniel, Zhou, Xi Kathy, Gjyrezi, Ada, Chanel-Vos, Chantal, Shen, Ruoqian, Tagawa, Scott T., Bander, Neil H., Nanus, David M., Giannakakou, Paraskevi
Publicado em 2011

The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer

Por Beltran, Himisha, Jendrisak, Adam, Landers, Mark, Mosquera, Juan Miguel, Kossai, Myriam, Louw, Jessica, Krupa, Rachel, Graf, Ryon P, Schreiber, Nicole, Nanus, David M, Tagawa, Scott T, Marrinucci, Dena, Dittamore, Ryan, Scher, Howard I
Publicado no Clin Cancer Res (2015)

Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer

Por Tagawa, Scott T., Milowsky, Matthew I., Morris, Michael, Vallabhajosula, Shankar, Christos, Paul, Akhtar, Naveed H., Osborne, Joseph, Goldsmith, Stanley J., Larson, Steve, Taskar, Neeta Pandit, Scher, Howard I., Bander, Neil H., Nanus, David M.
Publicado em 2013

Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal Treatment-Related Neuroendocrine Prostate Cancer

Por Mosquera, Juan Miguel, Beltran, Himisha, Park, Kyung, MacDonald, Theresa Y, Robinson, Brian D, Tagawa, Scott T, Perner, Sven, Bismar, Tarek A, Erbersdobler, Andreas, Dhir, Rajiv, Nelson, Joel B, Nanus, David M, Rubin, Mark A
Publicado em 2013